Dr. Nali Hada She is a Medical Officer and Heart and Lung Program Coordinator at …
Read More »Oxford’s ChAdOx1 NipahB Vaccine Enters Human Trials
The University of Oxford recently conducted a groundbreaking clinical trial, marking the initiation of the first-in-human testing phase for the ChAdOx1 NipahB vaccine. Developed by researchers at the University’s Pandemic Sciences Institute, this critical trial, led by the Oxford Vaccine Group, is financially backed by the Coalition for Epidemic Preparedness …
Read More »
Medicosnext













